Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Aims: To investigate midlife cholesterol in relation to Alzheimer’s disease (AD) and vascular dementia (VaD) in a large multiethnic cohort of women and men. Methods: The Kaiser Permanente Northern California Medical Group (healthcare delivery organization) formed the database for this study. The 9,844 participants underwent detailed health evaluations during 1964–1973 at ages 40–45 years; they were still members of the health plan in 1994. AD and VaD were ascertained by medical records between 1 January 1994 and 1 June 2007. Cox proportional hazards models – adjusted for age, education, race/ethnic group, sex, midlife diabetes, hypertension, BMI and late-life stroke – were conducted. Results: In total, 469 participants had AD and 127 had VaD. With desirable cholesterol levels (<200 mg/dl) as a reference, hazard ratios (HR) and 95% CI for AD were 1.23 (0.97–1.55) and 1.57 (1.23–2.01) for borderline (200–239 mg/dl) and high cholesterol (≥240 mg/dl), respectively. HR and 95% CI for VaD were 1.50 (1.01–2.23) for borderline and 1.26 (0.82–1.96) for high cholesterol. Further analyses for AD (cholesterol quartiles, 1st quartile reference) indicated that cholesterol levels >220 mg/dl were a significant risk factor: HR were 1.31 (1.01–1.71; 3rd quartile, 221–248 mg/dl) and 1.58 (1.22–2.06; 4th quartile, 249–500 mg/dl). Conclusion: Midlife serum total cholesterol was associated with an increased risk of AD and VaD. Even moderately elevated cholesterol increased dementia risk. Dementia risk factors need to be addressed as early as midlife, before underlying disease(s) or symptoms appear.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Findings in late-life cohorts vary, with some finding higher levels of cholesterol associated with a lower risk356 and others finding a higher risk for VaD.357”
In the citing paper
“there are several controllable risk factors including obesity [156,157], hyperlipidemia [158,159], hypertension [160,161,162,163], type 2 diabetes [164,165,166,167], and sedentary lifestyle [168] that can be addressed in an effort to decrease the risk of developing AD.”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [158]
In the citing paper
“Obesity,71–73 dyslipidemia,74–77 and high BP78,79 are also major contributors to vascular brain health.”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [75]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Hachinski, V., Iadecola, C., Petersen, R. C., Breteler, M. M., Nyenhuis, D. L., Black, S. E., Powers, W. J., DeCarli, C., Merino, J. G., Kalaria, R. N., et al. (2006) · Stroke · doi:10.1161/01.str.0000237236.88823.47 · Cited by 1,722 · cited 1×
“significantly increased the risk of developing VaD 3 decades later. High cholesterol levels (≥240 mg/dl) tended to increase VaD risk as well, but the association did not reach statistical significance. One reason for this could be the small sample size of VaD (127 persons in total, 39 with high cholesterol).VaD repres…”
BackgroundKrieger, N. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.5.703 · Cited by 1,654 · cited 1×
“The present study investigates further the cholesterol-dementia relationship by focusing on the 2 main dementia subtypes, AD and vascular dementia (VaD), in a larger Kaiser Permanente cohort with updated follow-up information. We also examined the full range of cholesterol values (not just high cholesterol, >240 mg/dl…”
BackgroundMidlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238 · cited 1×
“High midlife cholesterol has previously been shown to be a risk factor for dementia in the multiethnic cohort of women and men from the Kaiser Permanente Medical Care Program of Northern California [”
BackgroundSelf-citationKivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70537-3 · Cited by 1,126 · cited 1×
“Although our cohort does not include persons with mixed dementia as recognized by ICD-9 CM, the concomitant presence of neurodegenerative and vascular pathologies in a portion of the sample cannot be excluded. Clinical Significance and ConclusionsPhysicians tend to confine AD and VaD to geriatric age borders, and addr…”
ResultSelf-citationSerum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease
Notkola, I.-L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 669
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Iivonen, S., Mannermaa, A., Tuomilehto, J., Nissinen, A., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00006 · Cited by 645
Self-citationIribarren, C., Sidney, S., Sternfeld, B., & Browner, W. S. (2000) · JAMA · doi:10.1001/jama.283.21.2810 · Cited by 482
Kalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., Ross, G. W., Havlik, R. J., & Launer, L. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2255 · Cited by 417 · cited 1×
“but no association was observed in the Honolulu Asia Aging Study (HAAS) or Framingham study [”
BackgroundCrossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain
BJÖRKHEM, I. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01725.x · Cited by 381
Cited by
Items 401–500 of 553
Powell, L., & Wallace, E. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00079-0 · Cited by 8
Gong, Q. S., Xie, L., Bi, M., & Yu, L. (2021) · Brain and Behavior · doi:10.1002/brb3.2236 · Cited by 5
“However, published studies on the association between lipid profiles and the risk of developing dementia have to date produced inconsistent results (Beydoun et al., 2011; Raffaitin et al., 2009; Reitz et al., 2010; Solomon et al., 2009).”
ResultGoncalves, J. F., Yu, W. C., & Garcia, L. R. (2021) · iScience · doi:10.1016/j.isci.2022.104082 · Cited by 7
“However, behavioral decline can be modified by genetics, diet, and the environment (Carlsson, 2010; Liu and Zhang, 2014; Ochoa et al., 2011; Solomon et al., 2009).”
BackgroundChen, D., Li, N., Lin, L., Deng, S., He-Ming, Z., & Liu, S. (2013) · Journal of Biomedical Optics · doi:10.1117/1.jbo.18.11.118003 · Cited by 4
Chung, S. J., Kim, J. H., Cho, J. H., Kim, G. S., Choi, S.-A., Lee, P. H., & Lee, J. H. (2013) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2013.10.006 · Cited by 4
Vascular Dementia and Cognitive Impairment
Seshadri, S. S., Economos, A., & Wright, C. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00017-7 · Cited by 4
Chui, H. C., & Ramirez-Gomez, L. A. (2016) · Wiley eBooks · doi:10.1002/9781118797662.ch4 · Cited by 4
Lah, J. J., Tandon, R., Zhao, L., Watson, C. M., Elmor, M. B., Heilman, C. J., Sanders, K., Hales, C. M., Yang, H., Loring, D. W., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2577025/v1 · Cited by 9
McCaulley, M. E. (2026) · Research Square · doi:10.21203/rs.3.rs-10999456/v1 · Cited by 5
Reducing CETP activity prevents memory decline in an Alzheimer’s disease mouse model
Phénix, J., Sarty, I. M., Katz, M. S., Cobá, A. V., Marure-Rojano, A. E., Nie, H., Kerksiek, A., Jerry, I., Berger, C. S., Kiss, R. S., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00482-w · Cited by 4
“Most if not all women affected by AD are post-menopausal, and are particularly at risk, often exhibiting lower HDL and higher LDL levels compared to men (Freedman et al, 2004; Matthews et al, 1989; Mosconi and Brinton, 2018; Solomon et al, 2009).”
Elefante, C., Beatino, M. F., Fustini, C., Lepri, V., Acierno, D., Scalzo, A., Petrozzi, L., Giampietri, L., Tognoni, G., Baldacci, F., et al. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251394747 · Cited by 3
“48 49-52 Our fi ndings fi t within this framework, suggesting that metabolic alterations may contribute to cognitive vulnerability.”
Ng, T. K. S., Beck, T. L., Liu, X., Desai, P., Holland, T. M., Dhana, K., Krueger, K. R., Wilson, R. S., Evans, D. A., & Rajan, K. B. (2025) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2025.105825 · Cited by 3
Saunders, C., & Spencer, J. P. E. (2012) · Nutrition and Aging · doi:10.3233/nua-2012-0008 · Cited by 3
Hassani, S., & Gorelick, P. B. (2024) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2024.100367 · Cited by 4
“Data from observational studies have suggested that high cholesterol levels in midlife may increase risk for subsequent dementia and Alz-heimer ’ s disease [64]; however, in late life, low cholesterol levels have been predictive of subsequent dementia [65] or no association has been observed.”
BackgroundLipids, brain ageing, dementia, and lipidomics
Poljak, A., Braidy, N., Wong, M. W. K., Liu, Y., Housseini, M., & Sachdev, P. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00012-4 · Cited by 4
Vascular Dementia and Cognitive Impairment
Seshadri, S. S., Caunca, M. R., & Rundek, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00018-1 · Cited by 3
Maladie d’Alzheimer et facteurs de risque vasculaire
Hanon, O., & Duron, E. (2011) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2011.03.004 · Cited by 6
Cholesterol, lipoproteins, and cognitive impairment
Nash, D. T. (2009) · Journal of clinical lipidology · doi:10.1016/j.jacl.2009.10.002 · Cited by 3
Vaderav, R. (2014) · International Journal of Neurology and Brain Disorders · doi:10.15436/2377-1348.14.006 · Cited by 3
“Animal studies showed that high fat diet impairs hippocampal neurogenesis in male wistar rats[3] and epidemiological studies support the view that dietary cholesterol is one of the causes for Alzheimer’s disease and vascular dementia[4].”
BackgroundStatin Use, Ageing, and Cognition: A Review
Stephenson, N. E., & Crowe, S. F. (2016) · Australian Psychologist · doi:10.1111/ap.12116 · Cited by 4
Elkana, O., Dayman, V., Franko, M., Israel, A., Ravona‐Springer, R., Segev, S., & Beeri, M. S. (2018) · Experimental Aging Research · doi:10.1080/0361073x.2017.1422585 · Cited by 3
Serotonin – lipid interactions and their role in behavior
Kalinichenko, L. S., Gulbins, E., Kornhuber, J., & Müller, C. P. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00016-5 · Cited by 4
Jasmin, S. B. (2011) · eScholarship@McGill (McGill) · doi:10.82308/52384 · Cited by 4
Agitation in Patients with Dementia - Challenges in Diagnosis and Treatment
Sommer, O. H. (2010) · NVA (Nasjonalt vitenarkiv) · Cited by 3
Arafa, A., Kawachi, H., Kato, Y., Nosaka, S., Teramoto, M., Khairan, P., Gao, Q., Matsumoto, C., & Kokubo, Y. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123244 · Cited by 2
Hu, N., Yan, Y., Wei, S., Lv, H., Dang, L., Gao, L., Wang, J., Guo, X., Wang, J., Qu, Q., et al. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcli.2025.106959 · Cited by 3
do Nascimento, N. B., Farias, H. R., Schons, T., Padilha, A. P. Z., da Costa, M. S., Peres, A. M., Santos¹, L. F. D. S., Dantas, R. M., Ramos, J. M. O., Rodrigues, M. S., et al. (2026) · Neurochemical Research · doi:10.1007/s11064-025-04658-7 · Cited by 2
Alzheimersche Demenz, Cholesterin und Statine: Berührungspunkte wichtiger Stoffwechselwege
Silva, T., Teixeira, J., Remião, F., & Borges, F. (2012) · Angewandte Chemie · doi:10.1002/ange.201204964 · Cited by 2
White Matter Dementia: Origin, Development, Progress, and Prospects
Filley, C. M. (2016) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.16010003 · Cited by 3
Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential
Gutiérrez‐Merino, C. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.100672 · Cited by 2
CNS regulation of plasma cholesterol
Pérez–Tilve, D., Davidson, W. S., Tschöp, M. H., & Hofmann, S. M. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.590819 · Cited by 3
“On the one hand no correlation has been found between plasma cholesterol levels and risk of incidence of AD (32), but on the other hand moderately increased plasma cholesterol during the midlife has been associated with increased risk of dementia (33).”
BackgroundVASCULAR COGNITIVE IMPAIRMENT: POSSIBLE MECHANISMS OF DEVELOPMENT
Zueva, I., V (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-4-326-333 · Cited by 2
Chen, X., Liang, H., & Geiger, J. D. (2014) · PubMed · Cited by 4
Cholesterol Levels and Cognitive Impairments
Moreira, E. L. G., de Oliveira, J., Prediger, R. D., Farina, M., & Bem, A. F. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00068-9 · Cited by 3
Cook, E. A., & Testa, M. A. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-791-0_24 · Cited by 2
Midlife cholesterol level and dementia 32 years later
Haan, M. N. (2010) · Neurology · doi:10.1212/wnl.0b013e3181feb315 · Cited by 2
Andrén, E. A., Safi, D., Wallin, A., & Svensson, J. (2024) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2024.100229 · Cited by 3
“Risk factors for VaD development include higher age as well as deteriorated cardiometabolic status in midlife [4,9,10], and after stroke, 20 – 25 % of the patients develop delayed dementia [4,11].”
BackgroundResultVieira, A. A. D. S., Abatti, M. R., Michels, M., Goulart, A., Faller, C. J., Borges, H. D. M., Fernandes, F., Dominguini, D., Rocha, L. B., Córneo, E. D. S., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04937-y · Cited by 1
“Both parameters are related to cognitive decline, which is characteristic of neurodegenerative diseases[47–49].”
Lipid Lowering Agents and Late Life Cognitive Dysfunction
Stern, A., Teng, P., & Frishman, W. H. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000944 · Cited by 1
Chae, Y., Cho, Y., Lee, S. K., Go, E., Kim, C. G., & Cheon, S. Y. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115358 · Cited by 1
Lifestyle, genetic risk, plasma pTau217, and incident cognitive impairment in WRAP
Studer, R. L., Cody, K. A., Oomens, J. E., Reyes, R. E. R., Chin, N. A., Mueller, K. D., Hermann, B. P., Wilson, R. E., Langhough, R. E., Jonaitis, E. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70573 · Cited by 2
Axmann, H., & Lehrner, J. P. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01894-w · Cited by 1
“However, given conflicting evidence in the literature, further studies are needed [11–13 , 39].”
Tripathi, S. M., Shiells, H., Waymont, J. M. J., Staff, R. T., Schelter, B. O., Bentham, P., Wischik, C. M., & Murray, A. D. (2026) · Current Alzheimer Research · doi:10.2174/0115672050399596251106033110 · Cited by 2
The Medicinal Landscape of Chrysanthemum indicum L.: Bridging Traditional Wisdom and Modern Evidence
Liu, G., Alexa, E.-A., & Zhang, T. (2026) · Nutraceuticals · doi:10.3390/nutraceuticals6010017 · Cited by 1
“Although no neuronal or behavioural measures were performed, the lipid-lowering and immunomodulatory effects are indirectly relevant since systemic hypercholesterolemia and chronic immune activation are recognised risk factors for cerebrovascular and neurodegenerative disease [118,119].”
Rajalakshmi, R., M., R. C., Naaz, R., Madhunapantula, S. V., Uthaiah, C. A., & Salimath, P. V. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1696711 · Cited by 1
“Prior longitudinal studies have similarly shown that midlife metabolic dysfunction exerts stronger long-term cognitive consequences than late-life glycemic measures (Solomon et al., 2009).”
Hong, L.-W., Chiu, H.-H., Chiu, P., Wang, Y.-C., Yeh, H. C., & Kung, W. (2026) · iScience · doi:10.1016/j.isci.2026.116806 · Cited by 1
Vascular Cognitive Disorder: A Diagnostic and Pharmacological Treatment Updating
Russo, M. J., & Allegri, R. (2014) · Current Psychopharmacologye · doi:10.2174/2211556003666140702190144 · Cited by 1
“ar In general, the risk factors for VCI are the same as those for heart disease and stroke [3-9].”
BackgroundCholesterol Potentiates β-Amyloid Genesis in Cultured Human Umbilical Vein Endothelial Cells
Huang, G., Xue, Z., Hu, X., Wan, L., Li, J., Cai, Y., Patrylo, P. R., Luo, X.-G., Pan, A., & Yan, X. (2016) · Advances in Alzheimer s Disease · doi:10.4236/aad.2016.52002 · Cited by 1
Russo, M. J., & Allegri, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00015-x · Cited by 1
Pase, C. S., & Bürger, M. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811297-7.00014-7 · Cited by 1
Risk factors for the alzheimer's disease. Systematic review and meta-analysis
Khasanova, G. R., & Muzaffarova, M. S. (2024) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2023-8-4-101-114 · Cited by 1
Windon, C., & Elahi, F. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-49963-0_30 · Cited by 1
Wei, J., Lohman, M. C., Brown, M. J., Hardin, J. W., Yang, C., Merchant, A. T., & Friedman, D. B. (2024) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887241267315 · Cited by 3
Searcy, J. L. (2009) · UKnowledge (University of Kentucky) · Cited by 1
Relationship Between Cholesterol Metabolism, Apoe and Brain Volumes In Alzheimer‘s Disease
Leoni, V., & Caccia, C. (2011) · Future Neurology · doi:10.2217/fnl.11.38 · Cited by 2
“Hypercholesterolemia and dyslipidemia in midlife are to be considered risk factors for cardiovascular diseases and were found to be positively associated with AD development [83–88].”
BackgroundVascular Dementia and Vascular Cognitive Decline
Seshadri, S. S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10017-x · Cited by 1
Juárez‐Cedillo, T., & Drier-Jonas, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81892 · Cited by 3
The Brain-Behavior Link: A Conundrum
Nair, K. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-35437-4_4 · Cited by 1
Role of cholesterol in cognitive function in the elderly
Deshpande, V. K., & Doda, V. (2021) · Annals of Geriatric Education and Medical Sciences · doi:10.18231/j.agems.2021.013 · Cited by 1
Cholesterol and Dementia: A Possible Therapeutic Approach
Alavez-Rubio, J. S., & Juárez‐Cedillo, T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_13 · Cited by 1
Concept of Amnesia and Dementia in the Unani System of Medicine
Zakir, M., Khanam, S., Alam, M. T., Perveen, A., & Kazmi, M. H. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_21 · Cited by 1
The care and feeding of the leader's brain
McDowell, S. (2016) · doi:10.35613/ccl.2016.1025 · Cited by 1
The effects of midlife diet on late-life cognition : an epidemiological approach
Eskelinen, M. H. (2014) · UEF eRepo (University of Eastern Finland) · Cited by 7
Is stroke the cause of vascular dementia? A two-sample Mendelian Randomization analysisPreprint
Zhang, K., Chen, L., Zhang, P., Sun, X., Qu, Y., Yi, Y., & Guo, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-2015772/v1 · Cited by 1
Virta, J. J. (2012) · UTUPub (University of Turku) · Cited by 1
Arden, J. (2015) · Wiley eBooks · doi:10.1002/9781119171683.ch2
Potential Blood Biological Markers of Alzheimer's Disease
Metti, A. L. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Granic, A. (2011) · Digital Commons - University of South Florida (University of South Florida)
Cholesterol Metabolism in Huntington’s Disease
Leoni, V., Caccia, C., & Bjrkhem, I. (2012) · InTech eBooks · doi:10.5772/32654
Hiltunen, M. (2014) · Helda - University of Helsinki Institutional Repository
Genetic Determinants of Cognitive Function and Age-Related Brain Changes
Schuur, M. (2010) · RePub (Erasmus University Rotterdam) · Cited by 1
Downer, B. G. (2014) · UKnowledge (University of Kentucky)
van den Kommer, T. N. (2011) · Pure Amsterdam UMC
Nilsson, P. M., Román, G. C., Sellke, F. W., Seshadri, S. S., Arnett, K., Bennett, D. A., Chui, H. C., Higashida, R. T., Lindquist, R. D., Nyenhuis, D. L., et al. (2011)
Chui, H. C., Higashida, R. T., Lindquist, R. D., Nilsson, P. M., Petersen, C., Schneider, J. A., Tzourio, C., Arnett, D. K., Launer, L. J., Laurent, S., et al. (2013)
Amyloid Beta Accumulation in HIV-1 Infected Brain: The Role of Altered Cholesterol
Chen, X., Lü, H., & Jd, G. (2014)
Autoregulation of the Human Cerebrovasculature by Neurovascular Coupling
Farr, H. (2013) · UC Research Repository (University of Canterbury) · doi:10.26021/2326 · Cited by 1
“It has also been shown that atherosclerosis and high cholesterol – essentially “bad” vascular health – increases the risk of developing AD [134, 148].”
BackgroundPopulation-based studies on the natural history of Alzheimer's disease and vascular dementia
Imfeld, P. (2012) · edoc (University of Basel) · doi:10.5451/unibas-006021310
Do Increased Levels of Oxysterols Underlie Alzheimer’s Disease/Parkinson’s Disease Overlap?
Ghribi, O. (2012) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000e111
“[5] demonstrating that high cholesterol at mid-age increases the risk for AD by 66% later in life link cholesterol to the pathophysiology of AD.”
BackgroundCoffinger, S. P. (2016) · Digital Commons @ Butler University (Butler University)
Peculiarities in Dementia Treatment and Care in the Nursing Home
Socarrás, A. C. R. (2016)
Effects of high fat diet on cognition and brain pathology
Kosari, S. (2016) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27590118
Darwish, D. S. (2010) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.3252
“Humans studies report that high serum cholesterol is a risk factor for mild cognitive impairment and dementia (Foster, 2006; Kivipelto et al., 2001; Näslund et al., 2000; Solomon et al., 2007; Solomon et al., 2009; Teunissen et al., 2003; Yaffe et al., 2002).”
BackgroundInfluence of age, exercise and atrial fibrillation on the cerebrovascular function
Bráz, I. D. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
Alzheimer’s disease: Risk factors and therapeutic targets
Pokhrel, L. (2015) · Journal of Coastal Life Medicine · doi:10.12980/jclm.3.2015j5-57
“Interestingly, the high level of cholesterol during the mid life was related with the AD in late life[17].”
BackgroundEffects of long term high cholesterol diet on spatial learning in aged rats
Rong, S., Xu, R., Cheng, J., Chen, M., Ding, C., Jing, Z., & Li, W. (2016) · Integrative Food Nutrition and Metabolism · doi:10.15761/ifnm.1000169
“The use of statin, a group of commonly used cholesterol-lowering drugs, were reported to have the protective effect that early statin use was significantly associated with a reduction in AD progression in mild-tomoderate AD patients [21,22].”
BackgroundSide-chain oxidized oxysterols as metabolic regulators in vivo
Ali, Z. (2017) · Figshare
Lorette, A. (2012)
Cholesterol Diet-Associated Changes in the Hippocampus - A Prelude to Alzheimer's Disease?
Brooks, S. W. (2016) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.5262
“…studies have investigated the correlation between oxysterol levels and neurodegenerative disease but their findings are somewhat inconsistent (Lutjohann et al., 2000; Heverin et al., 2004; Solomon et al., 2009b; Zuliani et al., 2011; Mateos et al., 2011a; Hughes et al., 2012; Hughes et al., 2013).”
BackgroundResultInfluentialLipid and Genetic Predictors of Midlife Cognitive Decline in Treated HIV-1 Infection
Mukerji, S. S. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Microangiopathie cérébrale et démence : de la physiopathologie aux perspectives thérapeutiques
Albaret, G., & Debette, S. (2018) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2018.02.003 · Cited by 1
Diyet Yağlarının Alzheimer Hastalığı Patolojisi Üzerine Potansiyel Koruyucu Etkileri
Karagöz, M. F., & Tek, N. A. (2018) · Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi · doi:10.22312/sdusbed.412464
Associação entre fatores de risco cardiovasculares e demência vascular definitiva
da Silva, M. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.7.2018.tde-05112018-151715
Risk factors for development of neurocognitive disorders
Gustavsson, A. (2019) · Lund University Publications (Lund University)
"Importance of CAIDE risk score for the early diagnosis of Alzheimer dementia"
Sandu, I. A., Ilie, A. C., Ștefăniu, R., Pîslaru, A. I., Abdulan, I. M., Alexa, I. D., & Ștefănescu, C. (2019) · Bulletin of Integrative Psychiatry · doi:10.36219/bpi.2019.04.05
Metadata
- Authors
- Solomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A.
- Affiliations
- University of Eastern Finland (FI)
- Boston University (US)
- Kaiser Permanente (US)
- Venue
- Dementia and Geriatric Cognitive Disorders
- Publisher
- S. Karger AG
- Published
- 2009
- Volume
- 28
- Issue
- 1
- Pages
- 75-80
- ISSN
- 1420-8008 (ISSN-L)
- 1421-9824
- PMC
- PMC2814023
- OpenAlex
- W2134458253
- Cited by
- 557
- References
- 22
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 36 · 2023: 25 · 2022: 31 · 2021: 42 · 2020: 31 · 2019: 34 · 2018: 37 · 2017: 32 · 2016: 39 · 2015: 27 · 2014: 41 · 2013: 39 · 2012: 42
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Dementia and Geriatric Cognitive Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kaiser Permanente
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK066308, DK066308)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, vascular dementia, dementia risk factors, total cholesterol, hypercholesterolemia, multi-ethnic cohort, men and women
- MeSH terms
- Adult, Aged, Alzheimer Disease, Cholesterol, Data Interpretation, Statistical, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Socioeconomic Factors, Dementia, Vascular, Cohort Studies, Proportional Hazards Models, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.